MicroRNA-223-3p levels in serum-derived extracellular vesicles predict regression of M2BPGi-based liver fibrosis after hepatitis C virus eradication by direct-acting antiviral agents.
Takanori SuzukiKentaro MatsuuraYoshihito NaguraKyoko ItoShintaro OgawaHayato KawamuraKei FujiwaraKatsuya NagaokaEtsuko IioTakehisa WatanabeHiromi KataokaYasuhito TanakaPublished in: Journal of gastroenterology (2024)
The miR-223-3p level in serum-derived EVs at EOT24W is a feasible predictor of regression of M2BPGi-based liver fibrosis after achievement of an SVR by DAA therapy.